[Correction added after online publication 17 September 2010: author affiliation details were corrected.]
Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans
Article first published online: 1 SEP 2010
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology
Clinical & Experimental Immunology
Volume 162, Issue 3, pages 407–414, December 2010
How to Cite
Olivieri, A., De Angelis, S., Dionisi, S., D'Annunzio, G., Locatelli, M., Marinaro, M., Bonato, V., Amendola, A., Songini, M., Velluzzi, F., Schirru, C., Cotichini, R., Stazi, M. A., Dotta, F., Lorini, R., Bottazzo, G. F. and Boirivant, M. (2010), Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans. Clinical & Experimental Immunology, 162: 407–414. doi: 10.1111/j.1365-2249.2010.04253.x
- Issue published online: 10 NOV 2010
- Article first published online: 1 SEP 2010
- Accepted for publication 27 July 2010
Fig. S1. (a) Individual values of serum aTGF-β1 in the three groups of Sardinian school children. Bars represent mean. (b) Relationship between serum aTGF-β1 values and time to diabetes onset in the IrAb+ school children who developed T1D. TGF-β1 values were modelled as a fractional polynomial function (degree = 3) of time to diabetes onset in the pre-diabetic individuals from the general population.
|CEI_4253_sm_FigS1.tif||9934K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.